<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib13">
 <label>13</label>
 <element-citation publication-type="journal" id="sref13">
  <person-group person-group-type="author">
   <name>
    <surname>Mueller</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Obermann</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Schulte</surname>
    <given-names>F.W.</given-names>
   </name>
   <name>
    <surname>Lange-Gruenweller</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Oestereich</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Elgner</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Glitscher</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hildt</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Singh</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Wendel</surname>
    <given-names>H.-G.</given-names>
   </name>
   <name>
    <surname>Hartmann</surname>
    <given-names>R.K.</given-names>
   </name>
   <name>
    <surname>Ziebuhr</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Gruenweller</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (-) and the eIF4A-inhibitor silvestrol</article-title>
  <source>Antivir. Res.</source>
  <volume>175</volume>
  <year>2020</year>
  <fpage>104706</fpage>
 </element-citation>
</ref>
